CD274 and neoplasm: There are several studies exploring the relationship between NTRK fusion and biomarkers for ICIs, including PD-L1 expression, microsatellite instability, and tumor mutation burden (TMB), which had been identified as predictive biomarkers for ICIs (115–117).